Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

AI Stock Picker
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Resources

Blog
Earnings
Partner Program

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RNA
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
RNA
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

RNA Similar Chart Price Prediction

The price of RNA is predicted to go up -7.53%, based on the high correlation periods with CHRW. The similarity of these two price pattern on the periods is 95.99%.

stocks logo

RNA

stocks logo

CHRW

Down: -7.53%Similarity: 95.99%

RNA Revenue Forecast

RNA EPS Forecast

RNA FAQs

What is bull’s view on RNA?

RNA stock has a bullish outlook with a price target of $72, as reiterated by HC Wainwright & Co. on January 10, 2025, reflecting a 144.4% upside. This optimism is driven by its innovative AOC platform and promising pipeline, including the FDA-cleared Phase 3 trials for key therapies targeting rare diseases. Additionally, its strong financial position and recent progress in clinical trials further support the bullish sentiment.

What is bear's view on RNA?

RNA stock faces bearish sentiment due to consistent insider selling, with 42 insider sales and no purchases in the past six months, signaling a lack of confidence. The stock recently traded at $28.92, and options data suggests a potential downside to $22.50, reflecting cautious investor positioning. Additionally, the stock has crossed below its 200-day moving average, indicating a weakening technical trend.

What is RNA revenue forecast for next quarter？

The market consensus for RNA's revenue in the upcoming quarter is projected to be approximately $1.975M USD.

What is RNA eps forecast for next quarter？

The market consensus for RNA's eps in the upcoming quarter is projected to be approximately $0.77 USD.

RNA VS S&P500

Ask Intellectia about RNA

RNA Analyst's Forecast

Ritu Baral

TD Cowen

Strong Buy

2024-10-21

Price Target

$56 → $78

Upside

+66.99%

TD Cowen raised the firm's price target on Avidity Biosciences to $78 from $56 and keeps a Buy rating on the shares. The firm updated its model and corresponding estimates in conjunction with its Q3 earnings preview.
Corinne Johnson

Goldman Sachs

Strong Buy

2024-09-24

Price Target

$59

Upside

+34.09%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
AI Stock PickerFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisStock Chart PatternsEarnings TradingAI Screener
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free

Hot Stocks

stocks logo

BRBR

Bellring Brands Inc

$76.16
0.90%
stocks logo

LAD

Lithia Motors Inc

$368.69
-0.21%
stocks logo

RBC

RBC Bearings Inc

$364.59
0.26%
stocks logo

DBX

Dropbox Inc

$31.85
-0.41%
stocks logo

ALTR

Altair Engineering Inc

$110.37
-0.04%
stocks logo

MUSA

Murphy USA Inc

$484
-1.02%
stocks logo

AIT

Applied Industrial Technologies Inc

$262.5
-0.53%
stocks logo

GNRC

Generac Holdings Inc

$141.74
-2.30%
stocks logo

WAL

Western Alliance Bancorp

$89.59
2.27%
stocks logo

UWMC

UWM Holdings Corp

$6.27
0.00%